logo

ZVRA

Zevra·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ZVRA fundamentals

Zevra (ZVRA) released its earnings on Nov 5, 2025: revenue was 26.10M (YoY +606.36%), beat estimates; EPS was -0.01 (YoY +98.55%), beat estimates.
Revenue / YoY
26.10M
+606.36%
EPS / YoY
-0.01
+98.55%
Report date
Nov 5, 2025
ZVRA Earnings Call Summary for Q3,2025
  • Miplyf Dominance: $26.1M Q3 revenue, 137 prescriptions, 66% coverage; European MAA submission progressing.
  • Financial Resilience: $230M cash, disciplined spending; gross-to-net adjustment resolved.
  • Pipeline Focus: Celiprolol enrollment 44/150; KP1077 phase II completed; VEDS interim data positive.
EPS
Revenue

Revenue & Expenses

ZVRA has released its 2025 Q3 earnings report, with revenue of 26.06M, reflecting a YoY change of 605.36%, and net profit of -544.00K, showing a YoY change of 98.36%. The Sankey diagram below clearly presents ZVRA's revenue sources and cost distribution.

Key Indicators

Zevra (ZVRA) key financial stats and ratios, covering profitability, financial health, and leverage.
Zevra (ZVRA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Zevra (ZVRA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Zevra (ZVRA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Zevra (ZVRA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Zevra (ZVRA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield